ClinicalTrialsFinder
RecruitingNCT03712774

Prospective Observational Trial to Evaluate Quality of Life After Neoadjuvant or Definitive Chemoradiation in Patients With Esophageal Cancer

Sponsor

Ludwig-Maximilians - University of Munich

Enrollment

60 participants

Start Date

Oct 12, 2018

Study Type

OBSERVATIONAL

Conditions

Esophageal CancerQuality of LifeChemoradiation

Summary

Prospective observational study to evaluate the Quality of life based on standardized EORTC questionaires as well as toxicities, functional and oncological outcomes in patients treated with neoadjuvant or definitive chemoradiation for esophageal Cancer.

Eligibility

Min Age: 18 Years

Inclusion Criteria5

  • histologically proven esophageal Cancer (SCC or adenocarcinoma) without distant metastases (except supraclavicular nodes)
  • indication for neoadjuvant or definitive chemoradiation using either cisplatin/5-FU or carboplatin/paclitaxel with curative intent
  • age \>= 18 years
  • written informed consent
  • ability to answer the standardized questionaires according to the treating physician

Exclusion Criteria6

  • age \< 18 years
  • Treatment with palliative intent
  • distant metastases (except supraclavicular nodes)
  • second malignancy
  • Prior systemic treatment for esophageal Cancer
  • Treatment in an interventional study

Interventions

OTHEREORTC QLQ C30

standardized questionaire

OTHEREORTC QLQ OES-18

standardized questionaire

OTHEREORTC OG-25

standardized questionaire

Locations(1)

Department of Radiation Oncology, University Hospital, LMU Munich

Munich, Bavaria, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03712774

Related Trials

CA-4948 in Combination With FOLFOX/PD-1 Inhibitor +/- Trastuzumab for Untreated Unresectable Gastric and Esophageal Cancer

NCT051871821 location

Resilience and Equity in Aging, Cancer, and Health (REACH)

NCT046742671 location

OPtimizing Technology to Improve Medication Adherence and BP Control (OPTIMA-BP)

NCT052937561 location

Aromatherapy for Mental Health Promotion in IVF Patients

NCT074806681 location

Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.

NCT0721770410 locations